Tag: NIFTY50

DRREDDY – Q3 FY26 Earnings Call – 21-Jan-26

Dr.Reddy’s topline growth hinges on Semaglutide/Abatacept execution and EM resilience, while margins face structural pressure from Lenalidomide exit, FX, and biosimilar delays; base case implies 6–8% revenue growth with 24–26% EBITDA, but bear-case risks skew asymmetric.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Semaglutide launches in Canada (May 2026, $50/unit) and India (March 2026, $30/unit), contributing $150–200M revenue. Abatacept EU approval (July 2027) and US Rituximab re-inspection (H1CY27) proceed as guided. EM grows 20% YoY; India sustains 15%+ organic growth. EBITDA margins recover to 24–26% on cost controls. Implication: 6–8% revenue growth; 10–12% EPS growth.

Continue reading “DRREDDY – Q3 FY26 Earnings Call – 21-Jan-26”

AXISBANK – Q3 FY26 Earnings Call – 26-Jan-26

Axis Bank’s base case sees NIM stabilizing near 3.6–3.7% with ROE at 14–15%, while bear case risks compression to 3.4–3.5% and ROE 12–13%. Bull case offers upside with NIM above 3.8% and ROE 16%+, hinging on deposit growth and digital monetization.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Triggers: Deposit growth converges in 15–18 months, retail disbursements sustain +20% YoY, no further rate cuts.
Outcome: NIM stabilizes at 3.6–3.7% (Q4 dip offset by 2027 rebalancing), credit costs 60–70 bps, ROE 14–15%. CET-1 remains >14% (AT1 issuance likely). Action: Model 58–60% retail mix by FY28, watch Neo platform monetization.

Continue reading “AXISBANK – Q3 FY26 Earnings Call – 26-Jan-26”

ICICIBANK – Q3 FY26 Earnings Call – 17-Jan-26

ICICIBANK’s outlook splits into Base Case with NIM steady at 3.0–4.3% and ROE 15–21%; Bear Case with margin compression to 2.8–4.0% and ROE 13–14%; Bull Case with NIM expansion above 3.1–4.4% and ROE 17–22%.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) PSL portfolio conformity achieved by H1-2027, limiting provisions to ₹12.83B; (2) Retail deposit repricing offsets 50% of repo cut impacts. Outcome: PBT grows 3–5% YoY (adjusted for provisions), with NIM stable at 4.20–4.30%. Loan growth sustains at 11–12% YoY, led by business banking. RoE holds at 15–16%. Signal: Credit card/personal loan growth recovers to 8–10% YoY by H2-2027.

Continue reading “ICICIBANK – Q3 FY26 Earnings Call – 17-Jan-26”

RELIANCE – Q3 FY26 Earnings Presentation – 16-Jan-26

Market Scenarios at a Glance — Base case: Brent $60–70/bbl, 5G ARPU flat, FMCG +15–20%, EBITDA +5–7%, margins stable. Bear case: Brent <$50, ARPU drops, margins shrink, debt rises. Bull case: Brent >$75, ARPU +10%, EBITDA +20%+, margins peak, debt falls. New Energy hinges on oil trends.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

  • Key Variables: Brent $60–70/bbl, 5G ARPU flat, FMCG revenue grows 15–20%.
  • Outcome: EBITDA growth 5–7%, Jio margins 51–52%, Retail margins 7.5–8%. Net debt/EBITDA stable at 0.55x; EPS growth 5–10%. New Energy projects delayed but on track.
Continue reading “RELIANCE – Q3 FY26 Earnings Presentation – 16-Jan-26”

WIPRO – Q3 FY26 Earnings Call – 16-Jan-26

FY’27 Outlook: Base case sees 0–2% growth, 17–17.3% margins, EPS flat–5%, $1B buybacks. Bear case warns 2–4% decline, margins 16.8–17%, EPS –10–15%. Bull case targets 4–6% growth, 17.5–18% margins, EPS +10–12%. Triggers: macro stability, AI spend, client budgets.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

  • Key Variables: Deal ramps align with 6-quarter timelines; EMR energy/manufacturing deals convert in H2’26; wage hikes at 5–7%.
  • Outcome: Revenue grows 0–2% YoY in FY’27, with H2’26 inflection. Margins hold at 17–17.3% on cost discipline. EPS flat to +5% YoY. Buybacks ($1B) supplement dividends; HARMAN synergies partially offset dilution. Trigger: Macro stability; client AI spend ramps post-budget cycles.
Continue reading “WIPRO – Q3 FY26 Earnings Call – 16-Jan-26”

INFY – Q3 FY26 Earnings Call – 14-Jan-26

FY’27 Outlook: Base case projects 4–6% revenue growth, stable 21–22% margins, and 8–10% EPS rise, backed by tariff resolutions, AI scaling, and discretionary rebound. Bear case warns of <2% growth, 19–20% margins, and flat EPS if tariffs persist and AI lags. Bull case eyes 8%+ revenue, 23%+ margins, and 15%+ EPS via AI-driven surges and M&A.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

  • Key variables: Tariff resolutions (Manufacturing stabilization), AI deal conversion (6 value pools scale), FS/EU discretionary rebound.
  • Outcome: Revenue growth 4–6% (FY’27), margins stable at 21–22% (productivity offsets wage hikes), EPS +8–10% YoY. Buybacks resume at $1–1.5 bn/year.
Continue reading “INFY – Q3 FY26 Earnings Call – 14-Jan-26”

HDFCBANK – Q3 FY26 Earnings Call – 17-Jan-26

HDFC Bank’s Base case projects loan growth at 14–16% with NIMs steady near 3.3–3.4% and EPS rising 12–15%. Bear case risks slower growth, NIM contraction to ~3.2%, and higher credit costs. Bull case offers expansion, NIMs above 3.5%, and EPS growth near 20%.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key variables: Deposit growth at 14–15%, LDR glides to 90% by FY27; no material provision surprises.

  • Outcome: Loan growth at 14–16%; NIMs stabilize at 3.3–3.4% as cost of funds declines. Credit costs at 35–40 bps. EPS grows 12–15%, RoA flat at ~1.9–2.0%.
  • Trigger: Granular deposit mobilization succeeds; branch scaling delivers 3x productivity. PSU pricing normalizes.
Continue reading “HDFCBANK – Q3 FY26 Earnings Call – 17-Jan-26”

TCS – Q3 FY26 Earnings Call – 12-Jan-26

FY27 Outlook: Weak North American spend and underperforming AI productivity cap revenue growth below 3% YoY, with margins stuck at 24–25%. EPS may drop 5–8%. Bull case (20% chance): Mega BFSI/Healthcare deals and Agentic AI adoption could drive 10%+ revenue growth, 27%+ margins, and a valuation premium for TCS.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) North America recovers to 4–6% YoY growth; (2) AI revenue sustains 15%+ QoQ growth.
Outcome: FY27 revenue grows 6–8% YoY (Int’l: 7–9%, India: 5–7%). Margins expand to 25.5–26.5% via productivity gains + AI scaling. EPS grows 8–10% on dividend continuity. Data center revenue kicks in by late FY28, adding 2–3% to long-term growth.

Continue reading “TCS – Q3 FY26 Earnings Call – 12-Jan-26”

HCLTECH – Q3 FY26 Earnings Call – 12-Jan-26

AI-led bookings may drive 5–6% revenue growth, with EBIT at 19% by FY27 and ROIC stabilizing at 40%+. India/RoW growth offsets USA/Europe softness. In a bear case, delayed AI adoption and restructuring could limit growth to 3–4%. Bullish scenarios see 7–8% growth, 20%+ EBIT, and ROIC exceeding 45% on accelerated enterprise AI adoption.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

AI-led bookings ($2.5B+/quarter) convert to revenue at 70%+ rates, driving 5–6% CC growth. EBIT recovers to 19% in FY27 as restructuring completes. ROIC stabilizes at 40%+ on Software segment scaling (Actian, Jaspersoft). India/RoW growth offsets USA/Europe softness. Key variables: AI services reach 15–20% of revenue; margin expansion to 19–20%.

Continue reading “HCLTECH – Q3 FY26 Earnings Call – 12-Jan-26”

Nifty Analysis Weekly Chart 2023/06/30 Friday

1–2 minutes

Nifty Weekly Chart – Elliott Wave Analysis

Continue reading “Nifty Analysis Weekly Chart 2023/06/30 Friday”